BHWM
VIVO

Bay Harbor Wealth Management’s Meridian Bioscience Inc VIVO Stock Holding History

Bay Harbor Wealth Management’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-8
Closed – – 433
2020
Q1 		$0 Hold
8
– – ﹤0.01% 424
2019
Q4 		$0 Hold
8
– – ﹤0.01% 401
2019
Q3 		$0 Hold
8
– – ﹤0.01% 405
2019
Q2 		$0 Hold
8
– – ﹤0.01% 445
2019
Q1 		$0 Hold
8
– – ﹤0.01% 440
2018
Q4 		$0 Buy
+8
New +$136 ﹤0.01% 412

Other funds holding VIVO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Bay Harbor Wealth Management's VIVO Position: Q2 2020 in Review

Bay Harbor Wealth Management sold out of Meridian Bioscience Inc (VIVO) in Q2 2020, closing a stake of 8 shares.

Bay Harbor Wealth Management first reported a position in VIVO in Q4 2018 and held it in 6 quarters. The position peaked at $0 in Q1 2020. 191 funds tracked by Wall St. Rank hold VIVO as of Q2 2020.

  • Bay Harbor Wealth Management reported no remaining Meridian Bioscience Inc position as of Q2 2020 after selling out during the quarter.
  • Bay Harbor Wealth Management sold 8 Meridian Bioscience Inc shares in Q2 2020.
  • Bay Harbor Wealth Management first reported a position in Meridian Bioscience Inc in Q4 2018 and held it in 6 quarters.
  • Bay Harbor Wealth Management's Meridian Bioscience Inc position peaked at $0 in Q1 2020.
  • 191 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q2 2020.

Based on Bay Harbor Wealth Management's 13F filing for Q2 2020, filed 16 Jul 2020.